Zola N'Dandu

Marianne Brodmann, MD, Prof is a vascular specialist at the Medical University of Graz, Austria. She has been trained in Internal Medicine at the University Hospital of Graz and her main focus, after specializing in Vascular Medicine (Angiology), is doing peripheral endovascular procedures. She is involved in many trials dealing with new endovascular techniques in both claudicants as well as CLI patients.

Dr. Mathews is an interventional cardiologist and endovascular specialist at Bradenton Cardiology Center in Bradenton, FL specializing in complex coronary interventions, structural heart procedures, endovascular therapies, and novel device research. He did his undergraduate training at Rensselaer Polytechnic Institute in Troy, NY receiving a degree in Biology and Electronic Media Arts & Communication and subsequently working in the multimedia technology sector. He later went on to graduate and professional training at Tufts University in Boston, MA where he received his MD and Master's in Health Communication at the Sackler School of Biomedical Sciences focusing on telemedicine and interactive education. He completed residency training and fellowship training in Cardiovascular Disease, Advanced Cardiac Imaging, and Interventional Cardiology at the Washington University School of Medicine in St. Louis, MO. He is currently global and national principal investigator in several trials and is actively involved in endovascular research.

Dr. Zola N’Dandu earned his medical degree from Eastern Virginia Medical School and completed training in Internal Medicine, Cardiology, and Interventional Cardiology at Ochsner Health, including advanced specialization in Peripheral Vascular Disease. He previously served as Section Head at Ochsner Medical Center–Kenner, where he developed a reputable program in Chronic Limb-Threatening Ischemia (CLTI). He currently practices at the Heart and Vascular Institute at Ascension Sacred Heart in Pensacola, Florida.

Dr. N’Dandu’s work centers on limb preservation through a multidisciplinary, collaborative approach to peripheral arterial disease (PAD). His clinical and academic interests include advanced infrapopliteal and inframalleolar interventions, as well as deep venous arterialization (DVA) for patients with limited options. He is actively engaged in research, innovation, clinical trials, and publication, and is dedicated to teaching residents and fellows. He also advocates for patient and community education to improve awareness, access, and outcomes in PAD care.

Dr. Wiechmann has been in private practice for 28 years with Vascular & Interventional Physicians in Gainesville, Florida, USA, with a particular interest in peripheral arterial disease & critical limb ischemia, abdominal aortic aneurysms, carotid intervention, and venous disease. He has been elected a Fellow in 4 different medical associations, including the Society of Interventional Radiology, the Society of Vascular Medicine, the American Heart Association, and the Outpatient Endovascular & Interventional Society (OEIS) and has served in many leadership roles in these societies. Dr. Wiechmann is a founding member of the Outpatient Endovascular & Interventional Society (OEIS), serves on the Board, and is past-President of OEIS. He has given over 270 invited lectures, has been principal investigator in numerous clinical trials in peripheral arterial intervention, carotid stenting, medical therapy for PAD, and stem cell therapy for critical limb ischemia, and is lead or co-author on over 35 peer-reviewed articles.

John H. Rundback, MD, FAHA, FSVMB, FSIR

John H. Rundback, MD, is an Interventional Radiologist in practice since 1993, and is the Managing Partner of Advanced Interventional & Vascular Services LLP as well as a partner in Premier Endovascular in NJ. Dr. Rundback is board-certified in radiology and holds a Certificate of Added Qualification in Angiography and Interventional Radiology. He has been recognized as a Top Doctor by Castle Connolly.

Dr. Rundback's clinical and research interests focus on peripheral arterial disease, particularly complex tibiopedal therapies and deep venous arterialization for limb salvage, as well as venous interventions, carotid stenting, endovascular aneurysm repair. He has served as the principal investigator in many multi-center trials, presented at over 300 conferences, and published more than 100 peer-reviewed articles. Additionally, Dr. Rundback sits on the Scientific Advisory Board for multiple Strategic Device Companies, is CMO of a the ORCA Clinical Trials Network, and serves as an advisor and editorial board member for several medical journals.

Dr. Rundback is a past member of the Board of Directors of the Society of Interventional Radiology Foundation the Board of VIVA Physicians. Currently, he is an active board member of the CLI Global Society.

Eric A. Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI, FSVM is the Director of Vascular Intervention and an interventional cardiologist at Beth Israel Deaconess Medical Center. He is also Section Head of Interventional Cardiology and Vascular Research at the Smith Center for Outcomes Research in Cardiology and an Associate Professor of Medicine at Harvard Medical School. Clinically, Dr. Secemsky splits his time attending in the cardiac catheterization lab, and the inpatient and outpatient vascular medicine services. Dr. Secemsky is the primary vascular interventionalist within the BIDMC catheterization lab, where he does complex venous and arterial procedures, with a focus on peripheral artery disease.

Dr. Secemsky leads the vascular and interventional research program at the Smith Center. His research involves utilizing real-world data to perform comparative effectiveness and outcomes research, with a focus on peripheral vascular disorders. Dr. Secemsky is involved in clinical trial design and implementation, and has served as an investigator on more than a dozen trials. Dr. Secemsky’s research program is funded by the National Institutes of Health, Harvard Medical School, extramural grants and philanthropy. Dr. Secemsky has authored more than 300 publications. He is an Associate Editor at Vascular Medicine and is on the Editorial Board at Circulation: Cardiovascular Interventions and Journal of SCAI. He is on the Board of Directors for the VIVA Foundation, PERT Consortium and the Society for Vascular Medicine, and is the co-chair of the Vascular Disease Council for SCAI.

Dr. Zola N’Dandu earned his medical degree from Eastern Virginia Medical School and completed training in Internal Medicine, Cardiology, and Interventional Cardiology at Ochsner Health, including advanced specialization in Peripheral Vascular Disease. He previously served as Section Head at Ochsner Medical Center–Kenner, where he developed a reputable program in Chronic Limb-Threatening Ischemia (CLTI). He currently practices at the Heart and Vascular Institute at Ascension Sacred Heart in Pensacola, Florida.

Dr. N’Dandu’s work centers on limb preservation through a multidisciplinary, collaborative approach to peripheral arterial disease (PAD). His clinical and academic interests include advanced infrapopliteal and inframalleolar interventions, as well as deep venous arterialization (DVA) for patients with limited options. He is actively engaged in research, innovation, clinical trials, and publication, and is dedicated to teaching residents and fellows. He also advocates for patient and community education to improve awareness, access, and outcomes in PAD care.

Born and raised in the Western Suburbs of Chicago. I have completed all of my educational and medical training in Chicago. I am a proud father of two young children. Currently I am dedicated to my podiatric practice and serve as the Associate Chief Medical Officer of our nationwide practice.

R. Clement Darling III, MD, FACS
Professor of Surgery, Albany Medical College
Chief, Division of Vascular Surgery
Director, The Institute for Vascular Health and Disease
Albany Medical Center Hospital, Albany, NY
Chair, SVS/ACS Inpatient Vascular Verification Program

Dr. Darling is Board Certified in both General and Vascular Surgery and is a Distinguished
Fellow of the Society for Vascular Surgery and Fellow of the American College of Surgeons.
He serves as Chief of the Division of Vascular Surgery and the Director of the Institute for
Vascular Health and Disease at Albany Medical Center, where he leads one of the largest
vascular health care systems in the United States.

He has participated in more than 60 clinical research trials focused on carotid disease,
peripheral arterial disease, and both open and endovascular therapies for AAA disease. Dr.
Darling has published over 200 peer-reviewed papers more than 150 book chapters.

An Internationally recognized speaker, he has lectured extensively around the world and
held numerous leadership roles in national & regional medical societies. He is Past
President of the Society for Vascular Surgery, the Eastern Society for Vascular Surgery, the
Vascular and Endovascular Surgery Society, and the New England Society for Vascular
Surgery.

Alik Farber is the Associate Chief Medical Officer for Surgical Services, Vice-Chair of the Department of Surgery and Chief of the Division of Vascular and Endovascular Surgery at Boston Medical Center. He is a Professor of Surgery and Radiology at Boston University School of Medicine.
Dr. Farber is a graduate of Brown University and obtained his medical degree from Harvard Medical School. He completed a residency in general surgery at Massachusetts General Hospital, a vascular surgery fellowship at Dartmouth-Hitchcock Medical Center and an endovascular surgery fellowship at the Southern Illinois School of Medicine. He received his MBA at the Heller School for Social Policy and Management at Brandeis University.
Dr. Farber’s clinical and research interest is in treatment of peripheral arterial disease. He was a National Co-Chair of the National Institutes of Health-sponsored Best Endovascular versus Best Surgical Therapy in Patients with Critical Limb Ischemia (BEST-CLI) trial, a randomized, controlled trial recently completed at 150 sites across North America, Europe and New Zealand.

Dr. Madassery is an Associate Professor of Vascular and Interventional Radiology (VIR) at Rush University Medical Center in Chicago and Rush Oak Park Hospital. He is the Director of The Advanced VIR Fellowship, the Director of Peripheral Vascular Interventions & CLTI Limb Preservation Program and the IVC Filter Clinic at Rush. Recently, is now Medical Director of VIR at Rush Oak Park Hospital.

He received his medical degree from Chicago Medical School, and both Radiology Residency and VIR Fellowship at Rush. Recently inducted as Fellow of the Society of interventional Radiology (FSIR) & the International Andreas Gruentzig Society (IAGS).

He has authored and co-authored numerous articles, and plethora of grand rounds & educational presentations nationally/globally. He is deeply involved with SIR, serving on Standards and Practices, current Chair of the SIR PAD Specialty Council, on the SIR Annual Meeting Committee and other roles. He reviewes for Journals such as JVIR, JSV-CIT, Journal of CLI, Frontiers in Cardiovascular Medicine & a Board member of the Alliance for Wound Care Stakeholders, in Washington, D.C.

Much of his practice is dedicated to Critical Limb Ischemia Revascularization and Limb Preservation. Recently, he published a multidisciplinary Comprehensive Limb Preservation Guidebook, entitled Limb Preservation for the Vascular Specialist, with over 60 co-authors. Other interests include Complex IVC Filter Retrievals, Dialysis Interventions, Venous Reconstructions, and Interventional Oncology. He founded and Directs the Peripheral Vascular Trainees Lab (PVTL), which had its Inagural meeting in 2024. Most importantly, he is joyously married, and father to two amazing children.

Dr. Zola N’Dandu earned his medical degree from Eastern Virginia Medical School and completed training in Internal Medicine, Cardiology, and Interventional Cardiology at Ochsner Health, including advanced specialization in Peripheral Vascular Disease. He previously served as Section Head at Ochsner Medical Center–Kenner, where he developed a reputable program in Chronic Limb-Threatening Ischemia (CLTI). He currently practices at the Heart and Vascular Institute at Ascension Sacred Heart in Pensacola, Florida.

Dr. N’Dandu’s work centers on limb preservation through a multidisciplinary, collaborative approach to peripheral arterial disease (PAD). His clinical and academic interests include advanced infrapopliteal and inframalleolar interventions, as well as deep venous arterialization (DVA) for patients with limited options. He is actively engaged in research, innovation, clinical trials, and publication, and is dedicated to teaching residents and fellows. He also advocates for patient and community education to improve awareness, access, and outcomes in PAD care.

Richard F. Neville, MD, FACS, DFSVS is currently Associate Director of INOVA Schar Heart and Vascular, Schar Chair of Vascular Surgery, and Chief of Wound care and Hyperbaric Medicine. Dr. Neville also has an academic appointment as Professor of Medical Education at the University of Virginia, and, Clinical Professor of Surgery at George Washington University where he previously held the position Ludwig Chief of the Division of Vascular Surgery. He also served as Chief of Vascular Surgery at Georgetown University for many years. Dr. Neville completed medical school at the University of Maryland and then general surgery residency at Georgetown University before moving on to a fellowship at the National Institutes of Health in endovascular device development. Dr. Neville then completed a vascular surgery fellowship under the direction of Dr. Robert Hobson. Dr. Neville is a Distinguished Fellow of the Society for Vascular Surgery, and a Fellow of the American College of Surgeons and a member of many other societies including the Southern Association for Vascular Surgery. Dr. Neville is a national and international lecturer having published of over 200 manuscripts, 250 abstracts, 35 book chapters, and 350 invited lectures while remaining actively involved in research and the education of students, residents, fellows, and other physicians. He has consistently been named to the Best Doctors in America, Washingtonian Top Docs, and Who’s Who in the World. His clinical interests include lower extremity revascularization; wound healing, amputation prevention, as well as hemodialysis access.

Eric A. Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI, FSVM is the Director of Vascular Intervention and an interventional cardiologist at Beth Israel Deaconess Medical Center. He is also Section Head of Interventional Cardiology and Vascular Research at the Smith Center for Outcomes Research in Cardiology and an Associate Professor of Medicine at Harvard Medical School. Clinically, Dr. Secemsky splits his time attending in the cardiac catheterization lab, and the inpatient and outpatient vascular medicine services. Dr. Secemsky is the primary vascular interventionalist within the BIDMC catheterization lab, where he does complex venous and arterial procedures, with a focus on peripheral artery disease.

Dr. Secemsky leads the vascular and interventional research program at the Smith Center. His research involves utilizing real-world data to perform comparative effectiveness and outcomes research, with a focus on peripheral vascular disorders. Dr. Secemsky is involved in clinical trial design and implementation, and has served as an investigator on more than a dozen trials. Dr. Secemsky’s research program is funded by the National Institutes of Health, Harvard Medical School, extramural grants and philanthropy. Dr. Secemsky has authored more than 300 publications. He is an Associate Editor at Vascular Medicine and is on the Editorial Board at Circulation: Cardiovascular Interventions and Journal of SCAI. He is on the Board of Directors for the VIVA Foundation, PERT Consortium and the Society for Vascular Medicine, and is the co-chair of the Vascular Disease Council for SCAI.

Dr. Kayssi is a vascular surgeon and chief of the Division of Vascular Surgery at Sunnybrook Health Sciences Centre in Toronto. He is an associate professor of surgery and program director of the Limb Preservation Fellowship at the University of Toronto. Ahmed obtained his medical degree from Queen’s University in Kingston, Ontario, before relocating to Toronto to pursue training in general and vascular surgery. He subsequently completed a fellowship in limb preservation and wound care under the supervision of Dr. Richard Neville in Fairfax, Virginia. Dr. Kayssi is a graduate of the Harvard School of Public Health, where he obtained a Master’s of Public Health focusing on quantitative methods, and also holds a Doctorate of Public Health in Health Policy and Management from the Johns Hopkins School of Public Health.

Dr. Zola N’Dandu earned his medical degree from Eastern Virginia Medical School and completed training in Internal Medicine, Cardiology, and Interventional Cardiology at Ochsner Health, including advanced specialization in Peripheral Vascular Disease. He previously served as Section Head at Ochsner Medical Center–Kenner, where he developed a reputable program in Chronic Limb-Threatening Ischemia (CLTI). He currently practices at the Heart and Vascular Institute at Ascension Sacred Heart in Pensacola, Florida.

Dr. N’Dandu’s work centers on limb preservation through a multidisciplinary, collaborative approach to peripheral arterial disease (PAD). His clinical and academic interests include advanced infrapopliteal and inframalleolar interventions, as well as deep venous arterialization (DVA) for patients with limited options. He is actively engaged in research, innovation, clinical trials, and publication, and is dedicated to teaching residents and fellows. He also advocates for patient and community education to improve awareness, access, and outcomes in PAD care.

Born and raised in the Western Suburbs of Chicago. I have completed all of my educational and medical training in Chicago. I am a proud father of two young children. Currently I am dedicated to my podiatric practice and serve as the Associate Chief Medical Officer of our nationwide practice.

Mary Costantino MD, FSIR is a Interventional Radiologist in Portland, Oregon. She is the Owner/Operator at Advanced Vascular Centers, Portland and co-owner of Advanced Vascular Centers, Eugene. She has been in the outpatient arena since 2011. Her practice is focused on llimb salvage, uterine fibroids and venous disease.

Dr. Yana Etkin is board certified vascular surgeon and a Professor of Surgery at the Zucker School of Medicine at Hofstra/ Northwell. She serves as the Associate Chief of Vascular and Endovascular Surgery and a Program Director for the Vascular Surgery Fellowship and Residency programs.

Dr. Etkin received her medical degree from the Downstate Medical Center. She completed a residency in General Surgery at Montefiore Medical Center and a fellowship in Vascular Surgery at the Hospital of the University of Pennsylvania.

Dr. Etkin is a passionate educator who mentored and trained numerous medical students, residents, and fellows. She is an active member of numerous committees in local, regional and national societies with current and past leadership roles. In 2023, she has been elected as one of the directors for the Vascular Surgery Board of the American Board of Surgery.

She maintains busy clinical practice with special expertise in aortic surgery, venous pathology, critical limb ischemia, and dialysis access. Dr. Etkin also runs an active clinical research program focused on novel vascular surgical techniques and patient outcomes. She has authored over 50 peer-reviewed articles and several book chapters. She is an Associate Editor for Annals of Vascular Surgery Brief Reports and Innovations journal and is on the editorial board of several other medical journals. She has been an invited speaker and has led workshops/courses at more than 70 regional, national and international programs.

Dr Kum received his medical degree from the National University of Singapore in 2000 and
subsequently embarked on his surgical training with the Royal College of Surgeons,
obtaining his Master of Medicine and Fellowship in 2007.
In 2009, he completed his Postgraduate Fellowship in Vascular and Endovascular Surgery at
the Prince of Wales Hospital, Sydney as well as at the Department of Angiology, Heart
Centre Leipzig. In 2012, he completed a second Fellowship on Advanced Techniques in
Diabetic Limb Salvage and Wound Care Techniques in Milan.
Since 2015, Dr Kum has been the Director of Vascular Surgery at Department of Surgery,
Changi General Hospital Singapore and he was subsequently appointed as a Visiting
Consultant in 2019. He currently maintains his practice at Mount Elizabeth Novena
Hospital, Singapore and is currently the CMO of M & L Healthcare. Dr Kum is the past President of the
Society for Vascular and Endovascular Surgeons of Singapore (SVESS) and is part of the organizing committee of
Critical Issues in Endovascular Therapy, a regional meeting organized by the society.
Dr Kum has a keen interest in clinical research revolving around Diabetic Limb Salvage. He is
one of the pioneers in Percutaneous Deep Arterialization for no-option Critical Limb
Ischemia for which he has authored or co-authored numerous papers. He is the PI or co-PI
for several industry or physician led studies. He is also a keen innovator who is currently
working on several disruptive technologies.

Dr. Zola N’Dandu earned his medical degree from Eastern Virginia Medical School and completed training in Internal Medicine, Cardiology, and Interventional Cardiology at Ochsner Health, including advanced specialization in Peripheral Vascular Disease. He previously served as Section Head at Ochsner Medical Center–Kenner, where he developed a reputable program in Chronic Limb-Threatening Ischemia (CLTI). He currently practices at the Heart and Vascular Institute at Ascension Sacred Heart in Pensacola, Florida.

Dr. N’Dandu’s work centers on limb preservation through a multidisciplinary, collaborative approach to peripheral arterial disease (PAD). His clinical and academic interests include advanced infrapopliteal and inframalleolar interventions, as well as deep venous arterialization (DVA) for patients with limited options. He is actively engaged in research, innovation, clinical trials, and publication, and is dedicated to teaching residents and fellows. He also advocates for patient and community education to improve awareness, access, and outcomes in PAD care.

Jill Sommerset, RVT, FSVU, is a vascular technologist with 25 years of experience in advanced vascular ultrasound and limb preservation. Currently, she is the director of ultrasound at Advanced Vascular Centers and HOPE Vascular & Podiatry. She is also the director of Clinical Education and Training at Aveera Medical. She is known for developing Pedal Acceleration Time (PAT). Jill is also an international speaker recognized for her contributions to vascular ultrasound and improving patient outcomes.

Professor Varcoe is a vascular surgeon at Sydney’s Prince of Wales Hospital where he is director of surgery, anaesthetics and perioperative services for the South Eastern Sydney Local Health District. He is also director of the Prince of Wales operating theatres and of the Vascular Institute, one of Australia’s most prestigious clinical trials centres. His clinical practice specialises in the minimally invasive treatment of aortic conditions, carotid disease and the full gamut of occlusive arterial disease of the lower limb for which he is internationally renowned.

He has a strong academic interest in novel stent and anastomotic technologies, the investigation of intimal hyperplasia, and cellular mechanisms, and has the first-in-man experience with the Absorb bioresorbable stent technology applied below-the-knee. In 2015, he completed his PhD and in 2020 he completed a Masters in Clinical Epidemiology focussing on clinical trial design and biostatistics at the University of Sydney.

He is a Professor at the University of New South Wales where he teaches regularly. He is founder and course director of the New South Wales Vascular meeting and the VERVE symposium, the largest annual endovascular summit in Australasia.

He is a member of numerous learned societies, has published more than 130 peer reviewed manuscripts, five book chapters, is an invited reviewer for multiple leading journal in the field of vascular medicine, intervention and science, is on the editorial board of several of those same journals. He has been invited to speak both nationally and internationally on more than 300 individual occasions.

Dr. Wiechmann has been in private practice for 28 years with Vascular & Interventional Physicians in Gainesville, Florida, USA, with a particular interest in peripheral arterial disease & critical limb ischemia, abdominal aortic aneurysms, carotid intervention, and venous disease. He has been elected a Fellow in 4 different medical associations, including the Society of Interventional Radiology, the Society of Vascular Medicine, the American Heart Association, and the Outpatient Endovascular & Interventional Society (OEIS) and has served in many leadership roles in these societies. Dr. Wiechmann is a founding member of the Outpatient Endovascular & Interventional Society (OEIS), serves on the Board, and is past-President of OEIS. He has given over 270 invited lectures, has been principal investigator in numerous clinical trials in peripheral arterial intervention, carotid stenting, medical therapy for PAD, and stem cell therapy for critical limb ischemia, and is lead or co-author on over 35 peer-reviewed articles.

Fadi A. Saab, M.D., is an interventional cardiologist specializing in endovascular revascularization of peripheral vascular disease, with a particular interest in critical limb ischemia (CLI). He also specializes in treating venous insufficiency and cardiac issues, including high blood pressure and carotid artery disease. Dr. Saab earned his medical degree from the Damascus University School of Medicine, Syria, and completed an internal medicine residency at Detroit Medical Center-Sinai Grace Hospital, affiliated with Wayne State University, Detroit, MI. He then completed a cardiology outcome research fellowship at University of Michigan, Ann Arbor; a noninvasive cardiology fellowship at St. John Hospital & Medical Center, Detroit, MI; and fellowships in cardiovascular medicine and interventional cardiology at Baystate Medical Center, affiliated with Tufts University School of Medicine, Springfield, MA. Dr. Saab is a fellow of the American College of Cardiology, the Society for Cardiac Angiography & Interventions, and the American Society of Echocardiography.. Saab is currently Medical Director of Endovascular Therapy and Director of Cardiovascular Research at Michigan Outpatient Vascular Institute in Dearborn, MI. Dr. Saab actively participates in clinical research and has authored multiple peer-reviewed publications. He is an active member of the CLI Global Society and chairs the Society's Publication Committee.

Sonya S. Noor, MD, FACS is an established Vascular Surgeon who started an independent practice BEVSA in 2007: 2 locations, in Buffalo, and in Williamsville NY. Dr. Noor has 21 years of experience. Her career in medicine began in 1992 after graduating from CMC moving to the United States, she completed a residency at SUNY in Syracuse, fellowship at the University at Buffalo and Arizona Heart Institute. Dr. Noor is a member of the AMA, the Western New York Vascular Society, and the EVS. She is the past president of the American College of Surgeons’ local chapter (ACS) and a member of the Society for Vascular Surgery (SVS).
Dr. Noor is dual board certified by the ABS is known internationally as aleading vascular surgeon,she is a Clinical Associate Professor, Department of Surgery, University of Buffalo, and is actively involved with teaching PA, medical, residents and fellows, since 2004.
She freqeuently serves as faculty on conferences such as CX, TED, OEIS, NCVH, VAM, EVS,and AMP, NHCC to name a few. She also serves as Medical Director of Endovascular Services at Buffalo General Medical Center and Gates Vascular Institute, Medical Director Access Care ,and Vascular Director at Jacobs Institute which is a unique medical technology Innovation center in Buffalo, NY. She recenlty added Advanced wound care services to HEr OBL access care which also offers HBOT.
Dr. Sonya Noor was awarded Top Vascular Surgeon in 2017, 2018, 2020 and 2021 and Women of Distinction 2018.and Buffalo Business first Entepreneours award 2023.

Dr. Zola N’Dandu earned his medical degree from Eastern Virginia Medical School and completed training in Internal Medicine, Cardiology, and Interventional Cardiology at Ochsner Health, including advanced specialization in Peripheral Vascular Disease. He previously served as Section Head at Ochsner Medical Center–Kenner, where he developed a reputable program in Chronic Limb-Threatening Ischemia (CLTI). He currently practices at the Heart and Vascular Institute at Ascension Sacred Heart in Pensacola, Florida.

Dr. N’Dandu’s work centers on limb preservation through a multidisciplinary, collaborative approach to peripheral arterial disease (PAD). His clinical and academic interests include advanced infrapopliteal and inframalleolar interventions, as well as deep venous arterialization (DVA) for patients with limited options. He is actively engaged in research, innovation, clinical trials, and publication, and is dedicated to teaching residents and fellows. He also advocates for patient and community education to improve awareness, access, and outcomes in PAD care.

Dr. Pradeep K. Nair, an interventional cardiologist, is Vice-Chairman of New Cardiovascular Horizons Conference in New Orleans, LA. He joined the Cardiovascular Institute of the South (CIS) in 2015. A native of Somerset Pennsylvania, he graduated with University Honors from Carnegie Mellon University and earned his medical doctorate at Drexel University College of Medicine. He completed his residency in internal medicine and fellowships in cardiovascular disease and interventional cardiology at the University of Pittsburgh Medical Center Presbyterian Campus where he was recognized with several awards of distinction for his cardiovascular research. He went on to complete a year of an advanced endovascular interventional fellowship under the mentorship of Craig Walker at the CIS in Houma, LA.

Dr. Nair is licensed by the State Board of Medicine in Pennsylvania and Louisiana. He is board certified in internal medicine, cardiovascular disease, interventional cardiology, nuclear cardiology and echocardiography. He currently practices in Houma, Gray and Zachary, Louisiana where he specializes in peripheral arterial/venous disease and interventions. He is a fellow of the American College of Cardiology (ACC) and the Society of Cardiac Angiography and Interventions. He serves Horizon's International Peripheral Group, Board of OEIS, ACC Vascular Disease Section Leadership Council, and CLI Global Society Publication Committee. He has authored multiple peer-reviewed publications, book chapters, and presented and performed Live Endovascular Cases at several cardiovascular meetings. Having a keen clinical research interest of novel interventional devices and therapies, he is dedicated to supporting the advancement of our field.